Neogenomics (NEO) Non Operating Income (2010 - 2026)
Neogenomics (NEO) reported Non Operating Income of -$12000.0 for Q1 2026, down 118.46% on a YoY basis from $65000.0 in Q1 2025, and down 114.29% quarter-over-quarter from $84000.0 in Q4 2025.
Neogenomics (NEO) Non Operating Income (2010 - 2026) Analysis & Trends
Neogenomics has reported Non Operating Income for 15 years, with the latest figure at -$12000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 118.46% year-over-year to -$12000.0; the trailing twelve-month figure through Mar 2026 stood at $219000.0 (up 529.41% YoY), and the FY2025 full-year result was $296000.0, up 178.1% from the prior year.
- Non Operating Income for Q1 2026 stood at -$12000.0, down from $84000.0 in the prior quarter.
- The five-year high for Non Operating Income was $730000.0 in Q2 2023, with the low at -$431000.0 in Q4 2024.
- Historically, Non Operating Income has averaged $19764.7 across 5 years, with a median of -$1000.0 in 2022.
- Annual changes were most pronounced in 2023 — Non Operating Income slumped 484.0% — and 2025, when it soared 24200.0%.
- Neogenomics' Non Operating Income stood at -$1000.0 in 2022, then soared by 12500.0% to $124000.0 in 2023, then plunged by 447.58% to -$431000.0 in 2024, then surged by 119.49% to $84000.0 in 2025, then slumped by 114.29% to -$12000.0 in 2026.
- The last three Non Operating Income figures came in at -$12000.0 (Q1 2026), $84000.0 (Q4 2025), and -$335000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -4.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 9.60 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 7.33 Mn |
| 10 | Neogenomics | 1.41 Bn | 1.27 Bn | 80.86 Mn | -12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | -431,000.00 |
| Sep 30, 2024 | 317,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -263,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Sep 30, 2023 | -96,000.00 |
| Jun 30, 2023 | 730,000.00 |
| Mar 31, 2023 | -114,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | -405,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | -930,000.00 |
| Sep 30, 2021 | 89,000.00 |
| Jun 30, 2021 | 171,000.00 |